Enterococcus faecalis

Antibiotic
% Susceptible
2010
% Susceptible
2012
% Susceptible
2014
% Susceptible
2016
% Susceptible
2018
Ampicillin
100
100 100 100 99
Azithromycin
-
-
-
- -
Aztreonam
-
-
-
- -
Cefazolin
-
-
-
- -
Cefepime
-
-
-
- -
Ceftazidime
-
-
-
- -
Ceftriaxone
-
-
-
- -
Cefuroxime
-
-
-
- -
Ciprofloxacin
61
72
69
77 75
Clarithromycin
-
-
-
- -
Clindamycin
-
-
-
- -
Doxycycline
20
20
23
24 24
Erythromycin
-
-
-
- 24
Gentamicin
71S
75S
75S
79S 79S
Imipenem
+
+
+
+ +
Levofloxacin 67 78 74 81 85
Meropenem +/- +/- +/- +/- +/-
Moxifloxacin + + + + +
Nitrofurantoin 99& 99& 99& 99& 99&
Oxacillin/Naf - - - - -
Penicillin 100 100 100 100 99
Piperacillin + + + + +
Piperacillin/tazo + + + + +
Ticarcillin/Clav +/- +/- +/- +/- +/-
Tobramycin S S S S S
TMP/SMX - - - - -
Unasyn/Aug + + + + +
Vancomycin 100 100 100 99 99
       
# Tested 758 752 770 742 832

Comments:  

 

Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections